| Dr Elizabeth Escalante, MD | |
|
700 Quincy Ave, 5th Fl, Scranton, PA 18510-1798 | |
| (570) 770-7546 | |
| (570) 770-7545 |
| Full Name | Dr Elizabeth Escalante |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Neonatal-perinatal Medicine |
| Location | 700 Quincy Ave, Scranton, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205811288 | NPI | - | NPPES |
| 001088550 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080N0001X | Pediatrics - Neonatal-perinatal Medicine | MD038456E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth Escalante, MD 700 Quincy Ave, 5th Floor, Scranton, PA 18510-1798 Ph: (570) 770-7546 | Dr Elizabeth Escalante, MD 700 Quincy Ave, 5th Fl, Scranton, PA 18510-1798 Ph: (570) 770-7546 |
News Archive
Alnylam Pharmaceuticals, Inc. has announced that it has filed a Clinical Trial Application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase 1/2 clinical trial with ALN-AAT, a subcutaneously administered investigational RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of AAT deficiency-associated liver disease (alpha-1 liver disease).
"What does it take to get to zero? While reflecting on the theme of this past World AIDS Day (Getting to zero, Zero new infections, Zero discrimination, Zero deaths), I asked myself this question," Lisa MacDonald, project manager at HealthBridge Foundation of Canada, writes in a Huffington Post Canada opinion piece.
Golimumab, a new tumour necrosis factor-α (TNF-α) inhibitor reduces the signs and symptoms of rheumatoid arthritis in patients who have previously received any other TNF-α inhibitor, and might be a good option for patients who have inadequate responses to one or two other TNF-α inhibitors, finds an Article published Online first and in this week's edition of The Lancet.
In today's troubled economy, keeping a sales force motivated to perform can be critical to the success of a business. That's why Novo Nordisk turned to Performance Plus Marketing (PPM) of Roswell, GA, to build an incentive program to support the launch of its Diabetes medication, Victoza(R). The campaign's unprecedented success resulted in the Incentive Marketing Association's Circle of Excellence Award for Best Sales Incentive Program.
A new analysis reveals that fewer than half of older patients successfully treated for colorectal cancer receive the recommended screening schedule to detect any recurrence of cancer.
› Verified 2 days ago
Ms. Alana Rickard, D.O Pediatrics Medicare: Medicare Enrolled Practice Location: 531 Mt Pleasant Dr, Scranton, PA 18503 Phone: 570-342-8500 Fax: 570-558-2290 | |
Marie S Lena, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 531 Mt Pleasant Dr, Scranton, PA 18503 Phone: 570-342-8500 Fax: 570-558-2290 | |
Mr. Vincent Luciano Ross, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 442 N Main Ave, Scranton, PA 18504 Phone: 570-347-5605 Fax: 570-347-5606 | |
Dr. Michael Rogan, MD Pediatrics Medicare: May Accept Medicare Assignments Practice Location: 2232 Pittston Ave, Scranton, PA 18505 Phone: 570-340-2100 | |
Violeta Marina Lizano, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 201 Smallacombe Dr, Scranton, PA 18508 Phone: 570-961-0171 Fax: 570-207-2411 | |
Christine Burke, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 959 Wyoming Ave, Scranton, PA 18509 Phone: 570-344-9684 Fax: 570-969-0968 |